A review of investigational drug viltolarsen, currently in development for the treatment of DMD.
Wallace Brownlee, MBChB, PhD, FRACP, reviews the mechanism of action of siponimod for multiple sclerosis and the outcomes of the EXPAND study.
The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada–Las Vegas discussed the leading challenges for those with Alzheimer disease.
The director of the Center for Neurological Restoration at Cleveland Clinic detailed the recent technological and therapeutic innovations and their advantages in treating Parkinson disease.
Key opinion leaders consider the use of nonsteroidal anti-inflammatory drugs to treat cardiomyopathy. 
The director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center discussed the history of the research and offered insight into the attempt to regenerate injured tissue in the brain.
The use of corticosteroids, prednisone, and deflazacort, in managing Duchenne muscular dystrophy.
The co-director of the Neurological Clinical Research Institute at Massachusetts General Hospital spoke to the need for more collaborative efforts in ALS research.
SAP Partner Banner